Clinical Trial: Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With T2DM

U.S., June 14 -- ClinicalTrials.gov registry received information related to the study (NCT07020949) titled 'Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With T2DM' on June 05.

Brief Summary: The aim of this trial is to investigate the safety, tolerability, pharmacokinetics, and efficacy of THDBH120 injection in participants with T2DM. This study includes three multiple-ascending dose cohorts.

Study Start Date: June 13, 2024

Study Type: INTERVENTIONAL

Condition: Diabetes Mellitus Type 2

Intervention: DRUG: THDBH120 injection

Participants received THDBH120 by subcutaneous injection.

DRUG: Placebo of THDBH120 injection

Participants received placebo by sub...